Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Hepatitis D Global Clinical Trials Review, H2, 2014

Published: Nov-2014 | Format: PDF | GlobalData | Number of pages: 58 | Code: MRS - 2047

 

GlobalData's clinical trial report, “Hepatitis D Global Clinical Trials Review, H2, 2014"" provides data on the Hepatitis D clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis D. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis D. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
 

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hepatitis D 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Hepatitis D Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Hepatitis D 28
Oct 01, 2014: REPLICor announces initiation of its Phase II clinical trial with REP 2139-Ca in combination with Pegasys in patients with hepatitis B / hepatitis D co-infection 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
F. Hoffmann-La Roche Ltd. 29
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 29
Eiger BioPharmaceuticals, Inc. 30
Clinical Trial Overview of Eiger BioPharmaceuticals, Inc. 30
REPLICor Inc. 31
Clinical Trial Overview of REPLICor Inc. 31
MYR GmbH 32
Clinical Trial Overview of MYR GmbH 32
Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
Hepatera LLC 34
Clinical Trial Overview of Hepatera LLC 34
C. H. Boehringer Sohn AG & Co. KG 35
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35
Clinical Trial Overview of Top Institutes / Government 36
The National Institute of Diabetes and Digestive and Kidney Diseases 36
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 36
German Liver Foundation 37
Clinical Trial Overview of German Liver Foundation 37
National Taiwan University Hospital 38
Clinical Trial Overview of National Taiwan University Hospital 38
Five Key Clinical Profiles 39


Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

 

List of Tables
 

Hepatitis D Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Hepatitis D Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hepatitis D Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hepatitis D Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 29
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Eiger BioPharmaceuticals, Inc., 2014* 30
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by REPLICor Inc., 2014* 31
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by MYR GmbH, 2014* 32
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 33
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Hepatera LLC, 2014* 34
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 35
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 36
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by German Liver Foundation, 2014* 37
Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 38


List of Figures
 

Hepatitis D Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hepatitis D Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing